--- title: "NRx Pharmaceuticals Prices $3.50 Stock Offering to Raise ~$18.8 Million; BTIG Leads" type: "News" locale: "en" url: "https://longbridge.com/en/news/288776569.md" description: "NRx Pharmaceuticals priced a $3.50 per share stock offering, raising approximately $18.8 million in net proceeds. BTIG led the underwriting of 5,714,286 common shares. The transaction, closed on June 4, 2026, allows for up to an additional $21.6 million if the over-allotment option is exercised. Directors and officers agreed to a 60-day lock-up period." datetime: "2026-06-04T21:23:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/288776569.md) - [en](https://longbridge.com/en/news/288776569.md) - [zh-HK](https://longbridge.com/zh-HK/news/288776569.md) --- # NRx Pharmaceuticals Prices $3.50 Stock Offering to Raise ~$18.8 Million; BTIG Leads NRx Pharmaceuticals entered into an Underwriting Agreement with BTIG, as representative of the underwriters, for a public offering of 5,714,286 shares of common stock at $3.50 per share. The company expects net proceeds of about $18.8 million, or $21.6 million if the underwriters exercise their 30-day option to purchase up to 857,142 additional shares. The offering was made off an effective shelf registration statement and closed on June 4, 2026. Directors and officers agreed to a 60-day lock-up. **Agreement details:** - **Agreement type**: Underwriting agreement for public offering of common stock - **Counterparty**: BTIG, as representative of the underwriters - **Signed / Effective**: Jun 03 2026 / same - **Duration / Termination**: At will - **Reason**: Raise capital for operations and corporate purposes Original SEC Filing: NRX Pharmaceuticals, Inc. \[ NRXP \] - 8-K - Jun. 04, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [NRXP.US](https://longbridge.com/en/quote/NRXP.US.md) - [NRXPW.US](https://longbridge.com/en/quote/NRXPW.US.md) ## Related News & Research - [NRx Pharmaceuticals plans underwritten offering of common stock, grants 15% overallotment option](https://longbridge.com/en/news/288482896.md) - [BUZZ-NRx Pharma dives on deep-discounted share offering](https://longbridge.com/en/news/288577916.md) - [New AI-powered puppy KPIs: Key Potty Indicators](https://longbridge.com/en/news/289668031.md) - [Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff](https://longbridge.com/en/news/289226736.md) - [BTIG Reaffirms Their Buy Rating on Lightspeed POS Inc (LSPD)](https://longbridge.com/en/news/289239083.md)